Pimentel, F.F. et al. 2021. SYNERGISTIC MECHANISMS OF ACTION: COMPARISON OF ADCC AND SIGNALING PATHWAYS INHIBITION BY TRASTUZUMAB BIOSIMILAR OR ORIGINATOR TRASTUZUMAB IN COMBINATION WITH PERTUZUMAB IN HER2+ BREAST CANCER CELL LINES. Mastology. 31, (Oct. 2021), 9. DOI:https://doi.org/10.29289/259453942021v31s2009.